Home › Chronic Myeloid Leukemia › Tennessee
Chronic Myeloid Leukemia clinical trials in Tennessee
5 studies for Chronic Myeloid Leukemia are looking for participants at sites in Tennessee.
Cities in Tennessee
HPC Offered for PRESERVE Expansion
- Tristar Centennial Medical Center, Nashville
RecruitingObservational study
Ages 12 to 80 · All sexes · Updated Nov 6, 2026 · NCT07145411A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
- Tristar BMT, Nashville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06163430Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1063, Chattanooga
- Ascentage Investigative Site #1089, Nashville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Sarah Cannon Cancer Institute, Nashville
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 1
Ages 12 and older · All sexes · Updated Mar 16, 2026 · NCT06994676From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.